Anna Tosi

851 citations
42 papers · 478 indexed · h-index 12
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Immunotherapy and Immune Responses (6 papers)CAR-T cell therapy research (5 papers)
Partner nations
ItalyUnited StatesFrance

In The Last Decade

Anna Tosi

39 papers receiving 471 citations

Peers

Anna Tosi
Comparison fields: 5 of 65
  • Oncology 181
  • Immunology 142
  • Molecular Biology 78
  • Immunology and Allergy 78
  • Surgery 64
Replace Masaya Yokota with:
Masaya Yokota Japan
Christopher J. Howlett Canada
Yoichi Ohiro Japan
Françoise Créchet France
Lesley A. Rabach United States
D V Messadi United States
Ayumi Fukuoka Japan
Rena Brauer United States
BW Altrock Netherlands
Tanja Reineke Switzerland
Anna Tosi relative to Masaya Yokota Japan Masaya Yokota's profile →
Citations per field
00.5×2.5×
Masaya Yokota · 1×
Citations per year

Countries citing papers authored by Anna Tosi

Since Specialization
Citations

This map shows the geographic impact of Anna Tosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tosi more than expected).

Fields of papers citing papers by Anna Tosi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tosi. The network helps show where Anna Tosi may publish in the future.

Co-authorship network of co-authors of Anna Tosi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tosi. A scholar is included among the top collaborators of Anna Tosi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tosi. Anna Tosi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 24
6 10
7 49
8 1
9 28
10 1
11 5
12 6
13 27
14 32
15
Retroperitoneal hemorrhage following bone marrow biopsy.
11
16 25
17 4
18 13
19 6
20
Idiopathic hypereosinophilic syndrome and "eosinophilic leukemia".
10

About Anna Tosi

Anna Tosi is a scholar working on Immunology and Allergy, Oncology and Genetics, having authored 42 papers that have together received 478 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology and Allergy (78 citations), Immunology (142 citations) and Oncology (181 citations). Anna Tosi has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Antonio Rosato, S. Fava, Roberta Sommaggio, M Luoni, Elisa Cappuzzello, Angelo Tocci, Antonino De Paoli, Paola Zanovello, Debora Carpanese and Alberto De Paoli. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026